Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases

作者: Heike Seifert , Eishu Hirata , Martin Gore , Komel Khabra , Christina Messiou

DOI: 10.1111/PCMR.12424

关键词:

摘要: Here, we retrospectively review imaging of 68 consecutive unselected patients with BRAF V600-mutant metastatic melanoma for organ-specific response and progression on vemurafenib. Complete or partial responses were less often seen in the central nervous system (CNS) (36%) bone (16%) compared to lung (89%), subcutaneous (83%), spleen (71%), liver (85%) lymph nodes/soft tissue P < 0.001. CNS was also most common site progression. Based this, tested vitro efficacy inhibitors PLX4720 dabrafenib presence cerebrospinal fluid (CSF). Exogenous CSF dramatically reduced cell death both inhibitors. Effective killing restored by co-administration a PI-3 kinase inhibitor. We conclude that vemurafenib is variable different organs being particularly prone resistance. Extrinsic factors, such as ERK- PI3K-activating factors CSF, may mediate inhibitor resistance CNS.

参考文章(29)
Matthew M. K. Chan, Lauren E. Haydu, Alexander M. Menzies, Mary W. F. Azer, Oliver Klein, Megan Lyle, Arthur Clements, Alexander Guminski, Richard F. Kefford, Georgina V. Long, The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition Cancer. ,vol. 120, pp. 3142- 3153 ,(2014) , 10.1002/CNCR.28851
Mary W. F . Azer, Alexander M. Menzies, Lauren E. Haydu, Richard F. Kefford, Georgina V. Long, Patterns of response and progression in patients with BRAF‐mutant melanoma metastatic to the brain who were treated with dabrafenib Cancer. ,vol. 120, pp. 530- 536 ,(2014) , 10.1002/CNCR.28445
Heike Niessner, Andrea Forschner, Bernhard Klumpp, Jürgen B. Honegger, Maria Witte, Antje Bornemann, Reinhard Dummer, Annemarie Adam, Jürgen Bauer, Ghazaleh Tabatabai, Keith Flaherty, Tobias Sinnberg, Daniela Beck, Ulrike Leiter, Cornelia Mauch, Alexander Roesch, Benjamin Weide, Thomas Eigentler, Dirk Schadendorf, Claus Garbe, Dagmar Kulms, Leticia Quintanilla‐Martinez, Friedegund Meier, Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases Cancer Medicine. ,vol. 2, pp. 76- 85 ,(2013) , 10.1002/CAM4.50
Eishu Hirata, Maria Romina Girotti, Amaya Viros, Steven Hooper, Bradley Spencer-Dene, Michiyuki Matsuda, James Larkin, Richard Marais, Erik Sahai, Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling Cancer Cell. ,vol. 27, pp. 574- 588 ,(2015) , 10.1016/J.CCELL.2015.03.008
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro, Manu Setty, Christina S Leslie, Yoko Oei, Alicia Pedraza, Jianan Zhang, Cameron W Brennan, James C Sutton, Eric C Holland, Dylan Daniel, Johanna A Joyce, CSF-1R inhibition alters macrophage polarization and blocks glioma progression Nature Medicine. ,vol. 19, pp. 1264- 1272 ,(2013) , 10.1038/NM.3337
Li Liu, Karen Duff, A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse Journal of Visualized Experiments. pp. 960- ,(2008) , 10.3791/960
Matteo S Carlino, Jason R Todd, Kavitha Gowrishankar, Branka Mijatov, Gulietta M Pupo, Carina Fung, Stephanie Snoyman, Peter Hersey, Georgina V Long, Richard F Kefford, Helen Rizos, None, Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma. Molecular Oncology. ,vol. 8, pp. 544- 554 ,(2014) , 10.1016/J.MOLONC.2014.01.003
Cerys S. Manning, Robert Jenkins, Steven Hooper, Holger Gerhardt, Richard Marais, Susanne Adams, Ralf H. Adams, Jacco van Rheenen, Erik Sahai, Intravital imaging reveals conversion between distinct tumor vascular morphologies and localized vascular response to Sunitinib IntraVital. ,vol. 2, ,(2013) , 10.4161/INTV.24790
Edwin Lok, Amy S. Chung, Kenneth D. Swanson, Eric T. Wong, Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid. Melanoma Research. ,vol. 24, pp. 120- 130 ,(2014) , 10.1097/CMR.0000000000000045